Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 178,446 | 194,616 | 166,448 | 169,601 | 91,663 |
| Operating Income | -178,446 | -194,616 | -166,448 | -169,601 | -91,663 |
| Interest Expense | 3,863 | 6,434 | 4,185 | 2,590 | 464 |
| Other Income | 2,643 | 4,503 | 2,902 | 8,733 | 2,932 |
| Pre-tax Income | -179,666 | -196,547 | -167,731 | -163,458 | -89,195 |
| Net Income Continuous | -179,666 | -196,547 | -167,731 | -163,458 | -89,195 |
| Net Income | $-179,666 | $-196,547 | $-167,731 | $-163,458 | $-89,195 |
| EPS Basic Total Ops | -1.99 | -2.23 | -2.08 | -2.08 | -2.27 |
| EPS Basic Continuous Ops | -1.99 | -2.23 | -2.08 | -2.08 | -2.27 |
| EPS Diluted Total Ops | -1.99 | -2.23 | -2.08 | -2.08 | -2.27 |
| EPS Diluted Continuous Ops | -1.99 | -2.23 | -2.08 | -2.08 | -2.27 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.23 | -2.08 | -2.08 | -2.27 |
| EBITDA(a) | $-172,192 | $-186,893 | $-160,757 | $-166,606 | $-90,400 |